Endoscopic Resection for Vascular Anomalies in Children: A New Standard

Ann Surg. 2023 Oct 1;278(4):e870-e875. doi: 10.1097/SLA.0000000000005832. Epub 2023 Feb 24.

Abstract

Objective: To report an innovative endoscopic surgery for subcutaneous vascular malformations and intramuscular fibro-adipose vascular anomaly (FAVA) at our center.

Background: Historically, open surgical resection has been the treatment of choice. Recent advances in minimally invasive surgery have led to the successful application of endoscopic resection techniques for the surgical management of diseases of soft tissue.

Methods: Patients who underwent endoscopic resection of vascular anomalies were included in this retrospective review. Data were extracted from our Vascular Anomalies Center database between September 2019 and October 2022, including sex, age, symptoms, diagnosis, sites of surgery, previous treatment, surgery, and follow-up.

Results: There were 13 females and 15 males in the current study, with ages ranging from 1 to 17 years. The diagnoses included microcystic lymphatic malformation (LM) (n = 8), Klippel-Trénaunay syndrome (n = 7), venous malformation (n = 6), FAVA (n = 6), and mixed cystic LM (n = 1). Surgical sites included the lower extremity (n = 24), abdominal wall (n = 2), upper extremity (n = 1), and thoracic wall (n = 1). Five patients had an intramuscular lesion (FAVA). The endoscopic technique used 2 or 3 small ports in a gas inflation manner. Surgery included thrombectomy, radical resection, and debulking of vascular anomalies. Postoperative sclerotherapy with bleomycin was performed through a drainage tube in 6 patients with microcystic LM. Technical success was obtained in 27 patients. The conversion to open surgery was performed in one patient owing to the deep location of the lesion. No wound-related complication was observed.

Conclusions: Endoscopic surgery is a minimally invasive, effective, and safe treatment for subcutaneous vascular malformations and intramuscular FAVA. This approach can set a new standard that minimizes wound complications and reduces recovery time in patients undergoing resection for benign soft-tissue lesions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bleomycin
  • Child
  • Endoscopy
  • Female
  • Humans
  • Lymphatic Abnormalities* / diagnosis
  • Lymphatic Abnormalities* / pathology
  • Male
  • Retrospective Studies
  • Sclerotherapy / methods
  • Treatment Outcome
  • Vascular Malformations* / diagnosis
  • Vascular Malformations* / surgery

Substances

  • Bleomycin